Cover Image
市場調查報告書

疼痛管理藥的全球市場:2016∼2020年

Global Pain Management Drugs Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 298326
出版日期 內容資訊 英文 94 Pages
訂單完成後即時交付
價格
Back to Top
疼痛管理藥的全球市場:2016∼2020年 Global Pain Management Drugs Market 2016-2020
出版日期: 2016年08月01日 內容資訊: 英文 94 Pages
簡介

全球疼痛管理藥市場,預計從2016年到2020年,以4.97%的年複合成長率(CAGR)擴大。在這個成長的背景中,有全世界的人口的高齡化。可是,學名藥的崛起,可能成為阻礙這個市場成長的要素。

本報告提供全球疼痛管理藥市場現狀與未來預測,疼痛的種類/各地區的趨勢,市場成長因素與課題,主要供應商分析等。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要的產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 市場主要值得看的地方
  • 疼痛管理的評估
  • 治療

第5章 產品研發線

  • 開發平台候補資訊

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各藥物等級市場區隔

  • 類鴉片物質
  • NSAID(非類固醇系抗發炎藥)
  • 其他
  • 類鴉片物質的全球市場
  • NSAID的全球市場

第8章 各種類的市場區隔

  • 肌肉骨骼疼痛
  • 術後/外傷性疼痛
  • 癌症性疼痛
  • 熱疼痛
  • 偏頭痛
  • 分娩疼痛
  • 纖維肌痛
  • 加熱痛
  • 牙科/臉疼痛
  • 兒童疼痛
  • 神經性疼痛
  • 肌肉骨骼疼痛藥的全球市場
  • 術後/外傷性疼痛藥的全球市場
  • 癌症性疼痛藥的全球市場
  • 熱疼痛藥的全球市場
  • 偏頭痛藥的全球市場
  • 分娩疼痛藥的全球市場
  • 纖維肌痛藥的全球市場
  • 加熱痛藥的全球市場
  • 牙科/臉疼痛藥的全球市場
  • 兒童疼痛藥的全球市場
  • 神經性疼痛藥的全球市場

第9章 地理區分

  • 南北美洲的疼痛管理藥市場
  • EMEA地區的疼痛管理藥市場
  • 亞太地區的疼痛管理藥市場

第10章 市場成長因素

第11章 成長因素與其影響

第12章 市場課題

第13章 成長因素與課題的影響

第14章 市場趨勢

第15章 業者情勢

  • 競爭模式
  • AstraZeneca
  • Endo International
  • Johnson & Johnson
  • Pfizer
  • Purdue Pharma
  • 其他卓越供應商
  • 簡稱一覽

第16章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR8628

About Pain

Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a variety of skills and techniques used for the treatment of pain.

Technavio's analysts forecast the global pain management drugs market to grow at a CAGR of 4.97% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global pain management drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs that are used for the management of pain.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Pain Management Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AstraZeneca
  • Endo International
  • Johnson & Johnson
  • Pfizer
  • Purdue Pharma

Other Prominent Vendors

  • Allergan
  • AstraZeneca
  • Baxter
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Durect
  • GlaxoSmithKline
  • Hospira
  • Merck
  • Novartis
  • Pain Therapeutics
  • F. Hoffmann-La Roche
  • Sanofi
  • UCB
  • Valeant
  • Taro Pharmaceuticals
  • Achelios Therapeutics
  • Alder Biopharmace-uticals
  • Amgen
  • CoLucid
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eli Lilly
  • GW Pharmaceuticals
  • Immune Pharmaceuticals
  • Innovative Med Concepts
  • NeurAxon
  • OptiNose
  • RedHill
  • Sorrento Therapeutics
  • SUDA
  • Teva
  • Tonix
  • Trigemina
  • WEX Pharmaceuticals
  • Zynerba Pharmaceuticals

Market driver

  • Increase in awareness of pain management drugs
  • For a full, detailed list, view our report

Market challenge

  • Preference for alternative therapies
  • For a full, detailed list, view our report

Market trend

  • Off-label drug usage
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Assessment of pain
  • Treatment

PART 05: Pipeline portfolio

  • Information on pipeline candidates

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by drug class

  • Opioids
  • NSAIDs
  • Other
  • Global opioids market
  • Global NSAIDs market

PART 08: Market segmentation by type

  • Musculoskeletal pain
  • Surgical and trauma pain
  • Cancer pain
  • Neuropathic pain
  • Migraine pain
  • Obstetrical pain
  • Fibromyalgia pain
  • Burn pain
  • Dental/facial pain
  • Pediatric pain
  • Global musculoskeletal pain drugs market
  • Global surgical and trauma pain drugs market
  • Global cancer pain drugs market
  • Global neuropathic pain drugs market
  • Global migraine pain drugs market
  • Global obstetrical pain drugs market
  • Global fibromyalgia pain drugs market
  • Global burn pain drugs market
  • Global dental/facial pain drugs market
  • Global pediatric pain drugs market

PART 09: Geographical segmentation

  • Pain management drugs market in Americas
  • Pain management drugs market in EMEA
  • Pain management drugs market in APAC

PART 10: Market drivers

  • Rise in older population
  • Promising pipeline
  • Increase in awareness of pain management drugs
  • Favorable regulatory scenario

PART 11: Impact of drivers

PART 12: Market challenges

  • Generic competition
  • Adverse effects
  • Preference for alternative therapies
  • Short-term relief
  • Threat of counterfeit products

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Increase in R&D activities
  • Off-label drug usage
  • Strategic alliances

PART 15: Vendor landscape

  • Competitive scenario
  • AstraZeneca
  • Endo International
  • Johnson & Johnson
  • Pfizer
  • Purdue Pharma
  • Other prominent vendors
  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Pain assessment
  • Exhibit 03: Types of pain scales
  • Exhibit 04: Treatment options for pain
  • Exhibit 05: Commonly used non-opioids for pain management
  • Exhibit 06: Commonly used adjuvant medicines for pain
  • Exhibit 07: Pain management
  • Exhibit 08: Pipeline portfolio: Major drug candidates under development for pain management
  • Exhibit 09: Global pain management drugs market 2015-2020 ($ billions)
  • Exhibit 10: Five forces analysis
  • Exhibit 11: Global pain management drugs market by drug class
  • Exhibit 12: Segmentation of global pain management drugs market by drug class, 2015
  • Exhibit 13: Global opioids market 2015-2020 ($ billions)
  • Exhibit 14: Key drivers and challenges of global opioids market
  • Exhibit 15: Global NSAIDs market 2015-2020 ($ billions)
  • Exhibit 16: Key drivers and challenges of global NSAIDs market
  • Exhibit 17: Global pain management drugs market segmentation by type
  • Exhibit 18: Global pain management drugs market segmentation 2015
  • Exhibit 19: Global musculoskeletal pain drugs market 2015-2020 ($ billions)
  • Exhibit 20: Global surgical and trauma drugs market 2015-2020 ($ billions)
  • Exhibit 21: Global cancer pain drugs market 2015-2020 ($ billions)
  • Exhibit 22: Global neuropathic pain drugs market 2015-2020 ($ billions)
  • Exhibit 23: Global migraine pain drugs market 2015-2020 ($ billions)
  • Exhibit 24: Global obstetrical pain drugs market 2015-2020 ($ billions)
  • Exhibit 25: Global fibromyalgia pain drugs market 2015-2020 ($ billions)
  • Exhibit 26: Global burn pain drugs market 2015-2020 ($ billions)
  • Exhibit 27: Global dental/facial pain drugs market 2015-2020 ($ billions)
  • Exhibit 28: Global pediatric pain drugs market 2015-2020 ($ billions)
  • Exhibit 29: Global pain management drugs market by type: YoY revenue and growth 2015-2020
  • Exhibit 30: Global pain management drugs market by geographical segmentation 2015
  • Exhibit 31: Global pain management drugs market revenue by geography 2015-2020 ($ billions)
  • Exhibit 32: Pain management drugs market in Americas 2015-2020 ($ billions)
  • Exhibit 33: Pain management drugs market in EMEA 2015-2020 ($ billions)
  • Exhibit 34: Pain management drugs market in APAC 2015-2020 ($ billions)
  • Exhibit 35: Global pain management drugs market: YoY revenue and growth based on geography 2015-2020
  • Exhibit 36: Impact of drivers
  • Exhibit 37: Challenges in global pain management drugs market
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Trends in global pain management drugs market
  • Exhibit 40: AstraZeneca: Key pain products segmentation by revenue 2014
  • Exhibit 41: AstraZeneca: YoY growth rate and revenue of Vimovo 2012-2014 ($ millions)
  • Exhibit 42: AstraZeneca: Key takeaways
  • Exhibit 43: Endo International: YoY growth rate and revenue of Opana ER 2012-2014 ($ millions)
  • Exhibit 44: Endo International: YoY growth rate and revenue of Voltaren 2012-2014 ($ millions)
  • Exhibit 45: Endo International: YoY growth rate and revenue of Lidoderm 2012-2014 ($ millions)
  • Exhibit 46: Endo International: YoY growth rate and revenue of Percocet 2012-2014 ($ millions)
  • Exhibit 47: Endo International: Key takeaways
  • Exhibit 48: Johnson & Johnson: Key takeaways
  • Exhibit 49: Pfizer: YoY growth rate and revenue of Lyrica 2012-2014 ($ billions)
  • Exhibit 50: Pfizer: YoY growth rate and revenue of Celebrex 2012-2014 ($ billions)
  • Exhibit 51: YoY growth rate and revenue of Relpax 2012-2014 ($ millions)
  • Exhibit 52: Pfizer: Key takeaways
  • Exhibit 53: Purdue Pharma: Key takeaways
Back to Top